Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: A novel anti-inflammation mechanism

Free Radical Biology and Medicine

Volumn 52, Issue 8, 2012, Pages 1307-1317

  Zheng, Yijie ^a   Xiong, Shudao ^a,b   Jiang, Pei ^a   Liu, Ronghua ^a   Liu, Xiaoming ^a   Qian, Jing ^a   Zheng, Xiujuan ^a   Chu, Yiwei ^a  

^a FUDAN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Corticosteroids; Free radicals; Lipopolysaccharide; miRNAs; RAW264.7

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 155; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOCYTE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DOWN-REGULATION; FEMALE; GLUCOCORTICOIDS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICRORNAS; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84862795379     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.01.031     Document Type: Article

References (50)

1. Coutinho, A. E.; Chapman, K. E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol. 335:2-13; 2011.
2. Moynagh, P. N. Toll-like, receptor signalling pathways as key targets for mediating the anti-inflammatory and immunosuppressive effects of glucocorticoids. J. Endocrinol. 179:139-144; 2003.
3. Taylor, D. R.; Jayaram, L.; Asher, M. I.; Epton, M. J. "As-required" combination therapy with inhaled corticosteroids and long-acting β-2 agonists for asthma: current evidence and recommendations. N. Z. Med. J. 121:106-118; 2008.
4. Hall, J.; Penrose, A.; Tomlin, A.; Reid, J. Differential prescribing of inhaled corticosteroids in New Zealand general practice. N. Z. Med. J. 116:563; 2003.
5. Virgili, F.; Canali, R.; Figus, E.; Vignolini, F.; Nobili, F.; Mengheri, E. Intestinal damage induced by zinc deficiency is associated with enhanced CuZn superoxide dismutase activity in rats: effect of dexamethasone or thyroxine treatment. Free Radic. Biol. Med. 26:1194-1201; 1999.
6. Takahira, R.; Yonemura, K.; Fujise, Y.; Hishida, A. Dexamethasone attenuates neutrophil infiltration in the rat kidney in ischemia/reperfusion injury: the possible role of nitroxyl. Free Radic. Biol. Med. 31:809-815; 2001.
7. Barnes, P. J.; Adcock, I. M. Glucocorticoid resistance in inflammatory diseases. Lancet 373:1905-1917; 2009.
8. Barnes, P. J. Mechanisms and resistance in glucocorticoid control of inflammation. J. Steroid Biochem. Mol. Biol. 120:76-85; 2010.
9. Tsurufuji, S.; Sugio, K.; Takemasa, F. The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature 280: 408-410; 1979.
10. Quante, T.; Ng, Y. C.; Ramsay, E. E.; Henness, S.; Allen, J. C.; Parmentier, J.; Ge, Q.; Ammit, A. J. Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1. Am. J. Respir. Cell Mol. Biol. 39:208-217; 2008.
11. Maneechotesuwan, K.; Yao, X.; Ito, K.; Jazrawi, E.; Usmani, O. S.; Adcock, I. M.; Barnes, P. J. Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS Med. 6: e1000076; 2009.
12. Usmani, O. S.; Ito, K.; Maneechotesuwan, K.; Ito, M.; Johnson, M.; Barnes, P. J.; Adcock, I. M. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am. J. Respir. Crit. Care Med. 172:704-712; 2005.
13. Zhao, Q.; Shepherd, E. G.; Manson, M. E.; Nelin, L. D.; Sorokin, A.; Liu, Y. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J. Biol. Chem. 280:8101-8108; 2005.
14. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297; 2004.
15. Ruby, J. G.; Jan, C. H.; Bartel, D. P. Intronic microRNA precursors that bypass Drosha processing. Nature 448:83-86; 2007.
16. Kim, V. N.; Nam, J. W. Genomics of microRNA. Trends Genet. 22:165-173; 2006.
17. Buchan, J. R.; Parker, R. Molecular biology: the two faces of miRNA. Science 318: 1877-1878; 2007.
18. Mestdagh, P.; Lefever, S.; Pattyn, F.; Ridzon, D.; Fredlund, E.; Fieuw, A.; Ongenaert, M.; Vermeulen, J.; De Paepe, A.; Wong, L.; Speleman, F.; Chen, C.; Vandesompele, J. The microRNA body map: dissecting microRNA function through integrative genomics. Nucleic Acids Res. 39:e136; 2011.
19. Tili, E.; Michaille, J. J. Resveratrol, microRNAs, inflammation, and cancer. J. Nucleic Acids 2011:102431; 2011.
20. Risoe, P. K.; Ryg, U.; Wang, Y. Y.; Rutkovskiy, A.; Smedsrod, B.; Valen, G.; Dahle, M. K. Cecal ligation and puncture sepsis is associated with attenuated expression of adenylyl cyclase 9 and increased miR142-3p. Shock 36:390-395; 2011.
21. Kurowska-Stolarska, M.; Alivernini, S.; Ballantine, L. E.; Asquith, D. L.; Millar, N. L.; Gilchrist, D. S.; Reilly, J.; Ierna, M.; Fraser, A. R.; Stolarski, B.; McSharry, C.; Hueber, A. J.; Baxter, D.; Hunter, J.; Gay, S.; Liew, F. Y.; McInnes, I. B. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl. Acad. Sci. U. S. A. 108:11193-11198; 2011.
22. Sonkoly, E.; Pivarcsi, A. MicroRNAs in inflammation. Int. Rev. Immunol. 28: 535-561; 2009.
23. Ma, X.; Becker, B. L.; Barker, J. R.; Li, Y. MicroRNAs in NF-κB signaling. J. Mol. Cell Biol. 3:159-166; 2011.
24. Taganov, K. D.; Boldin, M. P.; Chang, K. J.; Baltimore, D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103:12481-12486; 2006.
25. Liu, G.; Friggeri, A.; Yang, Y.; Park, Y. J.; Tsuruta, Y.; Abraham, E. miR-147, a micro-RNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc. Natl. Acad. Sci. U. S. A. 106:15819-15824; 2009.
26. Androulidaki, A.; Iliopoulos, D.; Arranz, A.; Doxaki, C.; Schworer, S.; Zacharioudaki, V.; Margioris, A. N.; Tsichlis, P. N.; Tsatsanis, C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31:220-231; 2009.
27. Chen, X. M.; Splinter, P. L.; O'Hara, S. P.; LaRusso, N. F. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem. 282: 28929-28938; 2007.
28. Hou, J.; Wang, P.; Lin, L.; Liu, X.; Ma, F.; An, H.; Wang, Z.; Cao, X. MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183:2150-2158; 2009.
29. Dai, R.; Phillips, R. A.; Zhang, Y.; Khan, D.; Crasta, O.; Ahmed, S. A. Suppression of LPS-induced interferon-γ and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 112:4591-4597; 2008.
30. Nahid, M. A.; Pauley, K. M.; Satoh, M.; Chan, E. K. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J. Biol. Chem. 284: 34590-34599; 2009.
31. Tili, E.; Michaille, J. J.; Cimino, A.; Costinean, S.; Dumitru, C. D.; Adair, B.; Fabbri, M.; Alder, H.; Liu, C. G.; Calin, G. A.; Croce, C. M. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- α stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179:5082-5089; 2007.
32. Kluiver, J.; Poppema, S.; de Jong, D.; Blokzijl, T.; Harms, G.; Jacobs, S.; Kroesen, B. J.; van den Berg, A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207:243-249; 2005.
33. Eis, P. S.; Tam, W.; Sun, L.; Chadburn, A.; Li, Z.; Gomez, M. F.; Lund, E.; Dahlberg, J. E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102:3627-3632; 2005.
34. Wang, Y. P.; Li, X. Y.; Song, C. Q.; Hu, Z. B. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol. Sin. 23:263-266; 2002.
35. McCoy, C. E.; Sheedy, F. J.; Qualls, J. E.; Doyle, S. L.; Quinn, S. R.; Murray, P. J.; O'Neill, L. A. IL-10 inhibits miR-155 induction by toll-like receptors. J. Biol. Chem. 285:20492-20498; 2010.
36. Li, L.; Whiteman, M.; Moore, P. K. Dexamethasone inhibits lipopolysaccharideinduced hydrogen sulphide biosynthesis in intact cells and in an animal model of endotoxic shock. J. Cell. Mol. Med. 13:2684-2692; 2009.
37. Kim, M. L.; Jeong, H. G.; Kasper, C. A.; Arrieumerlou, C. IKKα contributes to canonical NF-κB activation downstream of Nod1-mediated peptidoglycan recognition. PLoS One 5:e15371; 2010.
38. Xiong, S. D.; Yu, K.; Liu, X. H.; Yin, L. H.; Kirschenbaum, A.; Yao, S.; Narla, G.; DiFeo, A.; Wu, J. B.; Yuan, Y.; Ho, S. M.; Lam, Y. W.; Levine, A. C. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Int. J. Cancer 125:774-782; 2009.
39. Bhattacharyya, S.; Brown, D. E.; Brewer, J. A.; Vogt, S. K.; Muglia, L. J. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109:4313-4319; 2007.
40. Bordon, Y. A new vein of TLR biology. Nat. Rev. Immunol. 10:748; 2010.
41. Dambrova, M.; Zvejniece, L.; Skapare, E.; Vilskersts, R.; Svalbe, B.; Baumane, L.; Muceniece, R.; Liepinsh, E. The anti-inflammatory and antinociceptive effects of NF-κB inhibitory guanidine derivative ME10092. Int. Immunopharmacol. 10: 455-460; 2010.
42. Barnes, P. J. Corticosteroids: the drugs to beat. Eur. J. Pharmacol. 533:2-14; 2006.
43. Wang, P.; Hou, J.; Lin, L.; Wang, C.; Liu, X.; Li, D.; Ma, F.; Wang, Z.; Cao, X. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J. Immunol. 185:6226-6233; 2010.
44. O'Connell, R. M.; Taganov, K. D.; Boldin, M. P.; Cheng, G.; Baltimore, D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U. S. A. 104:1604-1609; 2007.
45. Yin, Q.; Wang, X.; McBride, J.; Fewell, C.; Flemington, E. B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J. Biol. Chem. 283:2654-2662; 2008.
46. Rodriguez, A.; Vigorito, E.; Clare, S.; Warren, M. V.; Couttet, P.; Soond, D. R.; van Dongen, S.; Grocock, R. J.; Das, P. P.; Miska, E. A.; Vetrie, D.; Okkenhaug, K.; Enright, A. J.; Dougan, G.; Turner, M.; Bradley, A. Requirement of bic/microRNA-155 for normal immune function. Science 316:608-611; 2007.
47. Thai, T. H.; Calado, D. P.; Casola, S.; Ansel, K. M.; Xiao, C.; Xue, Y.; Murphy, A.; Frendewey, D.; Valenzuela, D.; Kutok, J. L.; Schmidt-Supprian, M.; Rajewsky, N.; Yancopoulos, G.; Rao, A.; Rajewsky, K. Regulation of the germinal center response by microRNA-155. Science 316:604-608; 2007.
48. Thompson, R. C.; Herscovitch, M.; Zhao, I.; Ford, T. J.; Gilmore, T. D. NF-κB downregulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. J. Biol. Chem. 286:1675-1682; 2011.
49. Onda, K.; Nagashima, M.; Kawakubo, Y.; Inoue, S.; Hirano, T.; Oka, K. Mitogen-activated protein kinase kinase 1/extracellular signal-regulated kinase (MEK-1/ERK) inhibitors sensitize reduced glucocorticoid response mediated by TNFα in human epidermal keratinocytes (HaCaT). Biochem. Biophys. Res. Commun. 351:266-272; 2006.
50. Xin, W.; Zhang, L.; Sun, F.; Jiang, N.; Fan, H.; Wang, T.; Li, Z.; He, J.; Fu, F. Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitro. Phytomedicine 18:272-277; 2011.